Oaktree Acquisition Corp. III Life Sciences (OACC) Cash Flow Statement

The divergence between positive net income and negative operating cash flow suggests that reported earnings are driven by non-cash interest accruals or accounting adjustments rather than operational success. Investors should monitor this gap, as it indicates that the company's reported profitability provides no liquidity to support its ongoing search for a business combination.

The lack of positive free cash flow is expected for a SPAC, yet the trend suggests an increasing reliance on the trust account or sponsor support to maintain operations. This trajectory warrants further investigation into how much longer the current cash runway can support due diligence activities before the liquidation deadline.

This aggressive dividend policy may indicate a strategy to manage capital efficiency, but it also reduces the available cash buffer for the sponsor to navigate the search process. Analysts should consider whether such distributions limit the company's flexibility to execute a complex transaction in a volatile market.

The absence of meaningful working capital cycles confirms that the company's cash burn is driven almost entirely by fixed administrative and professional service costs. This suggests that future cash flow volatility will likely be tied to transaction-related expenses rather than operational working capital requirements.